# Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome

> **NCT01951001** · PHASE4 · COMPLETED · sponsor: **Gyeongsang National University Hospital** · enrollment: 255 (actual)

## Conditions studied

- Acute Coronary Syndrome
- Platelet Thrombus
- Bleeding

## Interventions

- **DRUG:** Prasugrel

## Key facts

- **NCT ID:** NCT01951001
- **Lead sponsor:** Gyeongsang National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2015-06
- **Final completion:** 2018-10
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2020-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01951001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01951001, "Fixed-dose vs. Phenotype-based PrAsugrel Dose to MATCH Therapeutic Zone in Asians With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01951001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*